Saigon – Hanoi Securities Joint Stock Company (SHS) has registered to sell all 1,362,248 shares of Pharmedic Pharmaceutical Company (PMC), equivalent to 14.6% of the company’s capital. The sale aims to restructure the investment portfolio. SHS’s CEO, Nguyen Chi Thanh, is also the Vice Chairman of PMC’s Board. PMC shares are currently trading on the HNX at 105,400 VND/share, and if the transaction is successful, SHS could earn about 143 billion VND. This move comes as PMC’s share price has only increased by less than 2% since the beginning of 2025. In terms of business performance, PMC reported revenue of 132 billion VND in Q2 2025, down nearly 4% year-on-year, with a net profit after tax of over 22 billion VND, down 8%. For the first six months of the year, revenue reached 258 billion VND, and net profit after tax was 45 billion VND.
Leave a Reply